Potential vitamin-drug interactions in children: at a pediatric emergency department

Ran D Goldman1, Sunita Vohra, Alex L Rogovik

  • 1Pediatric Ress in Emergency Ther. (PRETx) Program, Div. of Pediatric Emergency Med., BC Children's Hosp., Vancouver, British Columbia, Canada, and Division of Pediatric Emergency Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada. rgoldman@cw.bc.ca

Paediatric Drugs
|July 2, 2009
PubMed

Insights

Pediatric patients frequently experience potential vitamin-medication interactions, particularly those with chronic illnesses. Healthcare providers should carefully weigh the benefits against risks of concurrent vitamin and medication use in children.

Area of Science:

  • Pediatric Pharmacology
  • Nutritional Science
  • Clinical Pharmacy

Background:

  • Increased vitamin usage necessitates understanding potential drug interactions.
  • Reported interactions between vitamins and medications highlight safety concerns.

Purpose of the Study:

  • To determine the frequency and types of potential vitamin-medication interactions in pediatric patients.
  • To identify family characteristics associated with higher risk of these interactions.

Main Methods:

  • Cross-sectional study involving 1804 families with children aged 0-18 years.
  • Face-to-face interviews conducted at a Canadian pediatric emergency department.
  • Assessed potential vitamin-medication interactions within the preceding 3 months.

Main Results:

  • 11% of pediatric patients experienced potential vitamin-medication interactions.
  • Children with interactions were older, more likely to have chronic illnesses, and taking other medications.
  • Multiple potential interactions were common; child's sex and socioeconomic factors were not associated with interactions.

Conclusions:

  • Potential vitamin-medication interactions are prevalent in children.
  • Older children and those with chronic illnesses are at higher risk.
  • Balancing benefits and harms of concurrent vitamin-medication use is crucial for pediatric care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...